Evaluation of the Effectiveness of the Pecha Kucha-Supported Microteaching Method in Nursing Process Education
30 juin 2026 mis à jour par: Sevim Uzuncan, Istanbul University - Cerrahpasa
This randomized controlled study aims to evaluate the effectiveness of the Pecha Kucha-supported microteaching method in nursing process education among first-year nursing students.
Participants will be randomly assigned to either an intervention group receiving Pecha Kucha-supported microteaching or a control group receiving traditional instruction.
The effects of the intervention on nursing process competencies and learning motivation will be evaluated.
Aperçu de l'étude
Statut
Actif, ne recrute pas
Les conditions
Intervention / Traitement
Description détaillée
The nursing process is a systematic and scientific method that guides nursing care. Developing nursing students' competencies in the nursing process is essential for providing high-quality patient care. Innovative teaching methods may enhance students' learning experiences and improve educational outcomes.
This randomized controlled study aims to evaluate the effectiveness of the Pecha Kucha-supported microteaching method in nursing process education among first-year nursing students. Participants will be randomly assigned to an intervention group or a control group. The intervention group will receive Pecha Kucha-supported microteaching, while the control group will receive traditional instruction. Following the educational intervention, students will prepare nursing care plans during their clinical practice.
Outcomes will be evaluated using a Nursing Process Knowledge Form, the Instructional Materials Motivation Survey, and the Quality of Nursing Diagnoses, Interventions and Outcomes (Q-DIO) instrument. The study will assess the effects of the intervention on nursing process competencies and learning motivation.
Type d'étude
Interventionnel
Inscription (Réel)
100
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Avcılar
-
Istanbul, Avcılar, Turquie (Türkiye), 34310
- Istanbul University-Cerrahpasa, Florence Nightingale Faculty of Nursing
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Oui
La description
Inclusion Criteria:
- First-year nursing students
- Successfully completed prerequisite nursing courses
- Grade point average (GPA) of 1.80 or higher
- Voluntary agreement to participate in the study
- Providing written informed consent
Exclusion Criteria:
- Students repeating the course
- Graduates of Vocational School of Health Services programs
- Withdrawal from the study at any stage
- Failure to complete study assessments or data collection forms
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Recherche sur les services de santé
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Experimental Group
Nursing students who received a brief refresher lecture on the nursing process and participated in Pecha Kucha-supported microteaching activities based on case scenarios.
Students subsequently prepared individual nursing care plans during clinical practice.
|
Nursing students first received a brief refresher lecture on the nursing process.
The experimental group, consisting of 50 students, was then divided into five groups of 10 students each.
Each group was assigned a case scenario and a nursing diagnosis.
Students were asked to prepare a presentation using the Pecha Kucha-supported microteaching method based on the assigned case and nursing diagnosis.
One student from each group delivered the presentation on behalf of the group.
Feedback sessions were conducted following the presentations.
Subsequently, students prepared individual nursing care plans for patients cared for during clinical practice.
|
|
Comparateur actif: Control Group
Nursing students who received a brief refresher lecture on the nursing process and prepared group nursing care plans based on case scenarios.
Students subsequently prepared individual nursing care plans during clinical practice.
|
Nursing students first received a brief refresher lecture on the nursing process.
The control group, consisting of 50 students, was then divided into five groups of 10 students each.
Each group was assigned a case scenario and a nursing diagnosis.
Students were asked to collaboratively prepare a nursing care plan based on the assigned case and nursing diagnosis.
Following this activity, students prepared individual nursing care plans for patients cared for during clinical practice.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Quality of Nursing Diagnoses, Interventions and Outcomes
Délai: After completion of the educational intervention (approximately 4 weeks after baseline) and at the end of the clinical practice period (approximately 12 weeks after baseline).
|
The quality of nursing care plans will be evaluated using the Quality of Nursing Diagnoses, Interventions and Outcomes (Q-DIO) instrument.
The Q-DIO is a 29-item instrument designed to assess the quality of nursing documentation, including nursing diagnoses, nursing interventions, and nursing-sensitive patient outcomes.
The instrument consists of four domains: Nursing Diagnoses as Process, Nursing Diagnoses as Outcomes, Nursing Interventions, and Nursing-Sensitive Patient Outcomes.
Higher scores indicate higher quality and more comprehensive documentation of nursing diagnoses, interventions, and patient outcomes in nursing care plans.
|
After completion of the educational intervention (approximately 4 weeks after baseline) and at the end of the clinical practice period (approximately 12 weeks after baseline).
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Nursing Process Knowledge Level Assessment Form
Délai: At baseline and at the end of the clinical practice period (approximately 12 weeks after baseline).
|
Students' knowledge of the nursing process will be evaluated using the Nursing Process Knowledge Level Assessment Form developed by the researcher.
The form consists of 25 multiple-choice questions.
The questions assess students' knowledge related to the nursing process, including assessment, nursing diagnosis, planning, implementation, and evaluation stages.
The form was reviewed by three experts, and necessary revisions were made in line with expert feedback.
Higher scores indicate a higher level of knowledge regarding the nursing process.
|
At baseline and at the end of the clinical practice period (approximately 12 weeks after baseline).
|
|
Instructional Materials Motivation Survey
Délai: At the end of the clinical practice period (approximately 12 weeks after baseline).
|
Students' learning motivation will be evaluated using the Instructional Materials Motivation Survey (IMMS), which is based on Keller's ARCS (Attention, Relevance, Confidence, Satisfaction) motivation model.
The survey consists of 24 items and two subscales: Attention-Relevance and Confidence-Satisfaction.
The Attention-Relevance subscale evaluates students' interest in and perceived relevance of the instructional content, whereas the Confidence-Satisfaction subscale assesses students' confidence and satisfaction with the learning experience.
Responses are rated on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree).
Total scores range from 24 to 120, with higher scores indicating higher levels of learning motivation.
|
At the end of the clinical practice period (approximately 12 weeks after baseline).
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Les enquêteurs
- Chaise d'étude: Funda Büyükyılmaz, Professor, Istanbul University-Cerrahpasa, Florence Nightingale Faculty of Nursing
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
9 avril 2026
Achèvement primaire (Estimé)
30 juin 2026
Achèvement de l'étude (Estimé)
30 juin 2026
Dates d'inscription aux études
Première soumission
23 juin 2026
Première soumission répondant aux critères de contrôle qualité
30 juin 2026
Première publication (Réel)
1 juillet 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
1 juillet 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
30 juin 2026
Dernière vérification
1 juin 2026
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- 2025-749
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Description du régime IPD
Individual participant data will not be shared because the study involves educational data collected from nursing students, and participant confidentiality and privacy will be protected in accordance with ethical approval and institutional regulations.
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .